- Home
- TZUP vs STRO Comparison
TZUP vs STRO Comparison
Compare TZUP & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZUP
- STRO
- Stock Information
- Founded
- TZUP 2020
- STRO 2003
- Country
- TZUP United States
- STRO United States
- Employees
- TZUP N/A
- STRO N/A
- Industry
- TZUP
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TZUP
- STRO Health Care
- Exchange
- TZUP NYSE
- STRO Nasdaq
- Market Cap
- TZUP 48.0M
- STRO 50.0M
- IPO Year
- TZUP N/A
- STRO 2018
- Fundamental
- Price
- TZUP $7.97
- STRO $0.73
- Analyst Decision
- TZUP
- STRO Hold
- Analyst Count
- TZUP 0
- STRO 8
- Target Price
- TZUP N/A
- STRO $6.14
- AVG Volume (30 Days)
- TZUP 223.0K
- STRO 2.4M
- Earning Date
- TZUP 01-01-0001
- STRO 05-08-2025
- Dividend Yield
- TZUP N/A
- STRO N/A
- EPS Growth
- TZUP N/A
- STRO N/A
- EPS
- TZUP N/A
- STRO N/A
- Revenue
- TZUP $741.00
- STRO $66,434,000.00
- Revenue This Year
- TZUP N/A
- STRO N/A
- Revenue Next Year
- TZUP N/A
- STRO $1.29
- P/E Ratio
- TZUP N/A
- STRO N/A
- Revenue Growth
- TZUP N/A
- STRO N/A
- 52 Week Low
- TZUP $2.02
- STRO $0.52
- 52 Week High
- TZUP $9.20
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- TZUP N/A
- STRO 42.48
- Support Level
- TZUP N/A
- STRO $0.80
- Resistance Level
- TZUP N/A
- STRO $1.11
- Average True Range (ATR)
- TZUP 0.00
- STRO 0.14
- MACD
- TZUP 0.00
- STRO -0.02
- Stochastic Oscillator
- TZUP 0.00
- STRO 2.56
About TZUP THUMZUP MEDIA CORP
Thumzup Media Corp operates in the social media branding and marketing industry. The company operates in a single business segment which is social media marketing. The Thumzup App works on both iPhone and Android mobile operating systems and connects brands and people who use and love these brands. The easy-to-use dashboard allows advertisers to programmatically customize their campaigns. Cash payments are made to App users/creators through Venmo and PayPal.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.